There is also evidence that LUCAT1 expression correlates with inflammation in COPD patients and that TUG1, SNHG5, CASC2, and OIP5-AS1 expression levels correlate with the severity of airflow limitation, supporting their roles as potential biomarkers for COPD progression. Here, LUCAT1 is linked to chronic obstructive pulmonary disease.